Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 266

1.

Therapeutic strategies for pulmonary sarcoidosis.

James WE, Judson MA.

Expert Rev Respir Med. 2020 Jan 31:1-13. doi: 10.1080/17476348.2020.1721284. [Epub ahead of print]

PMID:
32003264
2.

Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns.

Judson MA.

F1000Res. 2019 Dec 30;8. pii: F1000 Faculty Rev-2149. doi: 10.12688/f1000research.20696.1. eCollection 2019. Review.

3.

Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT).

Birnie D, Beanlands RSB, Nery P, Aaron SD, Culver DA, DeKemp RA, Gula L, Ha A, Healey JS, Inoue Y, Judson MA, Juneau D, Kusano K, Quinn R, Rivard L, Toma M, Varnava A, Wells G, Wickremasinghe M, Kron J.

Am Heart J. 2020 Feb;220:246-252. doi: 10.1016/j.ahj.2019.10.003. Epub 2019 Oct 20.

PMID:
31911261
4.

Income and Other Contributors to Poor Outcomes in US Sarcoidosis Patients.

Harper LJ, Gerke AK, Wang XF, Ribeiro Neto ML, Baughman RP, Beyer K, Drent M, Judson MA, Maier LA, Serchuck L, Singh N, Culver DA.

Am J Respir Crit Care Med. 2019 Dec 11. doi: 10.1164/rccm.201906-1250OC. [Epub ahead of print]

PMID:
31825646
5.

Cannabinoid Oil Vaping-Associated Lung Injury and its Radiographic Appearance.

Conuel EJ, Chieng HC, Fantauzzi J, Pokhrel K, Goldman C, Smith TC, Tiwari A, Chopra A, Judson MA.

Am J Med. 2019 Nov 18. pii: S0002-9343(19)30976-3. doi: 10.1016/j.amjmed.2019.10.032. [Epub ahead of print]

PMID:
31751528
6.

The epidemic of drug-induced sarcoidosis-like reactions: a side effect that we can live with.

Judson MA.

J Intern Med. 2019 Nov 14. doi: 10.1111/joim.13008. [Epub ahead of print] No abstract available.

PMID:
31724232
7.

Responsiveness to Change and Establishment of the Minimal Clinically Important Difference for the Cutaneous Sarcoidosis Activity and Morphology Instrument.

Noe MH, Gelfand JM, Bryer JS, Price SN, Judson MA, Rosenbach M.

JAMA Dermatol. 2019 Nov 13. doi: 10.1001/jamadermatol.2019.3519. [Epub ahead of print] No abstract available.

PMID:
31721981
8.

New advances in the management of pulmonary sarcoidosis.

Culver DA, Judson MA.

BMJ. 2019 Oct 22;367:l5553. doi: 10.1136/bmj.l5553. Review.

PMID:
31641045
9.

The Relationship of Pleural Manometry With Postthoracentesis Chest Radiographic Findings in Malignant Pleural Effusion.

Chopra A, Judson MA, Doelken P, Maldonado F, Rahman NM, Huggins JT.

Chest. 2020 Feb;157(2):421-426. doi: 10.1016/j.chest.2019.08.1920. Epub 2019 Aug 28.

PMID:
31472154
10.

The diagnosis of sarcoidosis.

Judson MA.

Curr Opin Pulm Med. 2019 Sep;25(5):484-496. doi: 10.1097/MCP.0000000000000596.

PMID:
31365383
11.

Patient perspectives in sarcoidosis.

van Helmondt SJ, Polish LB, Judson MA, Grutters JC.

Curr Opin Pulm Med. 2019 Sep;25(5):478-483. doi: 10.1097/MCP.0000000000000602.

PMID:
31365382
12.

Rare case of parathyroid gland sarcoidosis presenting with hypercalcaemia.

Saha BK, Burns SL, Foulke LA, Judson MA.

BMJ Case Rep. 2019 Jul 15;12(7). pii: e230598. doi: 10.1136/bcr-2019-230598. Review.

PMID:
31308180
13.

Patient perspectives in sarcoidosis.

van Helmondt SJ, Polish LB, Judson MA, Grutters JC.

Curr Opin Pulm Med. 2019 Jun 24. doi: 10.1097/MCP.0000000000000602. [Epub ahead of print]

PMID:
31246592
14.

The diagnosis of sarcoidosis.

Judson MA.

Curr Opin Pulm Med. 2019 Jun 11. doi: 10.1097/MCP.0000000000000596. [Epub ahead of print]

PMID:
31192820
15.

Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes.

Sonzogni M, Hakonen J, Bernabé Kleijn M, Silva-Santos S, Judson MC, Philpot BD, van Woerden GM, Elgersma Y.

Mol Autism. 2019 May 22;10:23. doi: 10.1186/s13229-019-0277-1. eCollection 2019.

16.

Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis.

Judson MA, Preston S, Hu K, Zhang R, Jou S, Modi A, Sukhu I, Ilyas F, Rosoklija G, Yucel R.

Respir Med. 2019 Jun;152:14-19. doi: 10.1016/j.rmed.2019.03.012. Epub 2019 Mar 23.

PMID:
31128604
17.

Screening sarcoidosis patients for cardiac sarcoidosis: What the data really show.

Judson MA.

Respir Med. 2019 Jul - Aug;154:155-157. doi: 10.1016/j.rmed.2019.05.007. Epub 2019 May 16. No abstract available.

PMID:
31126731
18.

The development of sarcoidosis in patients receiving daclizumab: A case series from multiple clinical trials.

Judson MA, Elicker BM, Colby TV, Kwon S, de Windt E, Chalkias S, Prada C, Smirnakis K, Singhal P.

Respir Med. 2019 Mar;149:23-27. doi: 10.1016/j.rmed.2019.01.015. Epub 2019 Feb 1.

PMID:
30885425
19.

The Diagnosis of Sarcoidosis: Attempting to Apply Rigor to Arbitrary and Circular Reasoning.

Judson MA.

Chest. 2018 Nov;154(5):1006-1007. doi: 10.1016/j.chest.2018.06.012. No abstract available.

PMID:
30409355
20.

ICU Admission Muscle and Fat Mass, Survival, and Disability at Discharge: A Prospective Cohort Study.

Jaitovich A, Khan MMHS, Itty R, Chieng HC, Dumas CL, Nadendla P, Fantauzzi JP, Yucel RM, Feustel PJ, Judson MA.

Chest. 2019 Feb;155(2):322-330. doi: 10.1016/j.chest.2018.10.023. Epub 2018 Oct 28.

21.

Subcellular organization of UBE3A in human cerebral cortex.

Burette AC, Judson MC, Li AN, Chang EF, Seeley WW, Philpot BD, Weinberg RJ.

Mol Autism. 2018 Oct 19;9:54. doi: 10.1186/s13229-018-0238-0. eCollection 2018.

22.

Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice.

Gu B, Carstens KE, Judson MC, Dalton KA, Rougié M, Clark EP, Dudek SM, Philpot BD.

J Clin Invest. 2019 Jan 2;129(1):163-168. doi: 10.1172/JCI120816. Epub 2018 Nov 19.

23.

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.

Stern BJ, Royal W 3rd, Gelfand JM, Clifford DB, Tavee J, Pawate S, Berger JR, Aksamit AJ, Krumholz A, Pardo CA, Moller DR, Judson MA, Drent M, Baughman RP.

JAMA Neurol. 2018 Dec 1;75(12):1546-1553. doi: 10.1001/jamaneurol.2018.2295.

PMID:
30167654
24.

Monitoring cardiac sarcoidosis: The next frontier.

Judson MA.

Respir Med. 2018 Nov;144S:S5-S6. doi: 10.1016/j.rmed.2018.07.018. Epub 2018 Jul 26. No abstract available.

PMID:
30064896
25.

A sarcoidosis clinician's perspective of MHC functional elements outside the antigen binding site.

Judson MA.

Hum Immunol. 2019 Jan;80(1):85-89. doi: 10.1016/j.humimm.2018.05.007. Epub 2018 May 30. Review.

PMID:
29859205
26.

Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors.

Gkiozos I, Kopitopoulou A, Kalkanis A, Vamvakaris IN, Judson MA, Syrigos KN.

J Thorac Oncol. 2018 Aug;13(8):1076-1082. doi: 10.1016/j.jtho.2018.04.031. Epub 2018 May 12. Review.

27.

Drug-Induced Sarcoidosis-Like Reactions.

Chopra A, Nautiyal A, Kalkanis A, Judson MA.

Chest. 2018 Sep;154(3):664-677. doi: 10.1016/j.chest.2018.03.056. Epub 2018 Apr 24. Review.

PMID:
29698718
28.

Clinical Features of Extrapulmonary Sarcoidosis Without Lung Involvement.

James WE, Koutroumpakis E, Saha B, Nathani A, Saavedra L, Yucel RM, Judson MA.

Chest. 2018 Aug;154(2):349-356. doi: 10.1016/j.chest.2018.02.003. Epub 2018 Feb 14.

PMID:
29453944
29.

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.

Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR 3rd, Garey KW, Reboli A, Greenberg RN, Apewokin S, Lyon GM 3rd, Ostrosky-Zeichner L, Wu AHB, Tobin E, Nguyen MH, Caliendo AM.

Clin Infect Dis. 2018 May 17;66(11):1678-1686. doi: 10.1093/cid/cix1095.

PMID:
29438475
30.

Enhanced Operant Extinction and Prefrontal Excitability in a Mouse Model of Angelman Syndrome.

Sidorov MS, Judson MC, Kim H, Rougie M, Ferrer AI, Nikolova VD, Riddick NV, Moy SS, Philpot BD.

J Neurosci. 2018 Mar 14;38(11):2671-2682. doi: 10.1523/JNEUROSCI.2828-17.2018. Epub 2018 Feb 5.

31.

Endpoints in sarcoidosis: More like IPF or asthma?

Judson MA.

Respir Med. 2018 May;138S:S3-S4. doi: 10.1016/j.rmed.2017.11.010. Epub 2017 Nov 20. No abstract available.

PMID:
29174488
32.

Considerations regarding sarcoidosis in the bariatric surgical patient.

Kilby KA, Kilbourne CM, Judson MA, Bonville DJ, Beegle SH.

Surg Obes Relat Dis. 2018 Feb;14(2):219-224. doi: 10.1016/j.soard.2017.10.007. Epub 2017 Oct 16. Review.

PMID:
29150393
33.

Assessment of Mediastinal Lymph Node Size in Pneumococcal Pneumonia with Bacteremia.

Chopra A, Modi A, Chaudhry H, Yucel R, Rane N, Fantauzzi J, Hellwitz FJ, Judson MA.

Lung. 2018 Feb;196(1):43-48. doi: 10.1007/s00408-017-0071-9. Epub 2017 Nov 16.

PMID:
29147774
34.

Respiratory Medicine: Focus on Sarcoidosis: Editor's welcome.

Judson MA.

Respir Med. 2018 May;138S:S1-S2. doi: 10.1016/j.rmed.2017.10.017. Epub 2017 Oct 23. No abstract available.

PMID:
29102284
35.

Disease Burden and Variability in Sarcoidosis.

Gerke AK, Judson MA, Cozier YC, Culver DA, Koth LL.

Ann Am Thorac Soc. 2017 Dec;14(Supplement_6):S421-S428. doi: 10.1513/AnnalsATS.201707-564OT. Review.

36.

Clinical Course of Sarcoidosis in World Trade Center-Exposed Firefighters.

Hena KM, Yip J, Jaber N, Goldfarb D, Fullam K, Cleven K, Moir W, Zeig-Owens R, Webber MP, Spevack DM, Judson MA, Maier L, Krumerman A, Aizer A, Spivack SD, Berman J, Aldrich TK, Prezant DJ; FDNY Sarcoidosis Clinical Research Group*.

Chest. 2018 Jan;153(1):114-123. doi: 10.1016/j.chest.2017.10.014. Epub 2017 Oct 21.

37.

Quality of Life in Sarcoidosis.

Judson MA.

Semin Respir Crit Care Med. 2017 Aug;38(4):546-558. doi: 10.1055/s-0037-1602589. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750468
38.

Radiation therapists' perspectives on participating in research.

Halkett GKB, Berg M, Ebert MA, Cutt D, Davis M, Hegney D, House M, Judson M, Kearvell R, Krawiec M, Lester L, Maresse S, McLoone P, McKay J.

J Med Radiat Sci. 2017 Dec;64(4):299-309. doi: 10.1002/jmrs.237. Epub 2017 Jul 21.

39.

The Assessment of Cough in a Sarcoidosis Clinic Using a Validated instrument and a Visual Analog Scale.

Judson MA, Chopra A, Conuel E, Koutroumpakis E, Schafer C, Austin A, Zhang R, Cao K, Berry R, Khan MMHS, Modi A, Modi R, Jou S, Ilyas F, Yucel RM.

Lung. 2017 Oct;195(5):587-594. doi: 10.1007/s00408-017-0040-3. Epub 2017 Jul 13.

PMID:
28707109
40.

Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.

Judson MC, Burette AC, Thaxton CL, Pribisko AL, Shen MD, Rumple AM, Del Cid WA, Paniagua B, Styner M, Weinberg RJ, Philpot BD.

J Neurosci. 2017 Aug 2;37(31):7347-7361. doi: 10.1523/JNEUROSCI.0037-17.2017. Epub 2017 Jun 29.

41.

A necrotic tonsillar lesion: An unusual presentation of disseminated histoplasmosis.

Keen C, Lee H, Galati L, Fantauzzi J, Blinkhorn R, Jennings TA, Chaturvedi S, Judson MA.

Respir Med Case Rep. 2017 Jun 7;22:44-46. doi: 10.1016/j.rmcr.2017.06.003. eCollection 2017.

42.

A new subfamily of Feaellidae (Arachnida, Chelonethi, Feaelloidea) from Southeast Asia.

Judson MLI.

Zootaxa. 2017 Apr 26;4258(1):1-33. doi: 10.11646/zootaxa.4258.1.1.

PMID:
28609931
43.

The role of serum amyloid A staining of granulomatous tissues for the diagnosis of sarcoidosis.

Huho A, Foulke L, Jennings T, Koutroumpakis E, Dalvi S, Chaudhry H, Chopra A, Modi A, Rane N, Prezant DJ, Sheehan C, Yucel R, Patel M, Judson MA.

Respir Med. 2017 May;126:1-8. doi: 10.1016/j.rmed.2017.03.009. Epub 2017 Mar 8.

44.

A Bare-Bones Approach.

Lavery K, Gilden DJ, Saint S, Judson MA, Dhaliwal G.

N Engl J Med. 2017 Apr 6;376(14):1371-1376. doi: 10.1056/NEJMcps1516629. No abstract available.

PMID:
28379797
45.

Paradoxical Reactions and the Immune Reconstitution Inflammatory Syndrome.

Church LWP, Chopra A, Judson MA.

Microbiol Spectr. 2017 Mar;5(2). doi: 10.1128/microbiolspec.TNMI7-0033-2016. Review.

PMID:
28303782
46.

Readdressing the entity of exercise pulmonary arterial hypertension.

Medarov BI, Jogani S, Sun J, Judson MA.

Respir Med. 2017 Mar;124:65-71. doi: 10.1016/j.rmed.2017.02.012. Epub 2017 Feb 17. Review.

47.

Sarcoidosis extent relates to molecular variability.

Monast CS, Li K, Judson MA, Baughman RP, Wadman E, Watt R, Silkoff PE, Barnathan ES, Brodmerkel C.

Clin Exp Immunol. 2017 Jun;188(3):444-454. doi: 10.1111/cei.12942. Epub 2017 Mar 27.

48.

Reticuloendothelial system involvement in untreated sarcoidosis patients as assessed by 18F-FDG PET scanning.

Kalkanis A, Judson MA, Kalkanis D, Vavougios GD, Malamitsi J, Georgou E.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Dec 23;33(4):423-425.

PMID:
28079858
49.

Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease.

Judson MA.

Expert Rev Respir Med. 2017 Feb;11(2):111-118. doi: 10.1080/17476348.2017.1281745. Epub 2017 Jan 20. Review.

PMID:
28076979
50.

High frequency ultrasound: a novel instrument to quantify granuloma burden in cutaneous sarcoidosis.

Noe MH, Rodriguez O, Taylor L, Sultan L, Sehgal C, Schultz S, Gelfand JM, Judson MA, Rosenbach M.

Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(2):136-141. Epub 2017 Aug 25.

Supplemental Content

Loading ...
Support Center